(Q34544036)

2 August 2017

title

Chemerin as a novel non-invasive serum marker of intrahepatic lipid content in obese children (English)

1 reference

2 August 2017

0 references

Monika Kłusek-Oksiuta

object named as

Monika Kłusek-Oksiuta

1

0 references

Małgorzata Wojtkowska

4

object named as

Malgorzata Wojtkowska

1 reference

Irena Białokoz-Kalinowska

2 August 2017

2

object named as

Irena Bialokoz-Kalinowska

1 reference

2 August 2017

Eugeniusz Tarasów

3

1 reference

2 August 2017

Irena Werpachowska

5

1 reference

2 August 2017

Dariusz Marek Lebensztejn

6

1 reference

2 August 2017

publication date

17 November 2014

1 reference

Italian Journal of Paediatrics

2 August 2017

published in

1 reference

2 August 2017

volume

40

1 reference

2 August 2017

page(s)

84

1 reference

Creative Commons Attribution 4.0 International

2 August 2017

copyright license

start time

17 November 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1186/s13052-014-0084-4

0 references

cites work

Serum fetuin A concentration is elevated in children with non-alcoholic fatty liver disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237733

Ectopic fat and cardiometabolic and vascular risk.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237733

Chemerin is highly expressed in hepatocytes and is induced in non-alcoholic steatohepatitis liver

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237733

Pediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237733

Serum fetuin A and chemerin levels correlate with hepatic steatosis and regional adiposity in maintenance hemodialysis patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237733

Atherogenic dyslipidemia and cardiovascular risk in children with nonalcoholic fatty liver disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237733

Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237733

Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237733

Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237733

Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237733

Pediatric nonalcoholic fatty liver disease (NAFLD): a "growing" problem?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237733

Adipose tissue as an endocrine organ

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237733

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237733

Ultrasound scanning in the detection of hepatic fibrosis and steatosis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237733

T1-weighted dual-echo MRI for fat quantification in pediatric nonalcoholic fatty liver disease

7 July 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13052-014-0084-4

Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13052-014-0084-4

Serum chemerin and vaspin in non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13052-014-0084-4

Circulating vaspin levels and epicardial adipose tissue thickness are associated with impaired coronary flow reserve in patients with nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13052-014-0084-4

Sampling variability of nonparametric estimates of the areas under receiver operating characteristic curves: an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13052-014-0084-4

Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13052-014-0084-4

MRI in identifying hepatic steatosis in obese children and relation to ultrasonography and metabolic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13052-014-0084-4

Elevated hepatic chemerin mRNA expression in human non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13052-014-0084-4

Systemic inflammation in childhood obesity: circulating inflammatory mediators and activated CD14++ monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13052-014-0084-4

MR proton spectroscopy in liver examinations of healthy individuals in vivo

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4237733

Chemerin as a Mediator between Obesity and Vascular Inflammation in Children

27 October 2018

1 reference

https://api.crossref.org/works/10.1186%2FS13052-014-0084-4

Serum levels of vaspin, obestatin, and apelin-36 in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

12 December 2020

Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease

1 reference

12 December 2020

Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN Hepatology Committee

1 reference

12 December 2020

Identification of chemerin as a novel FXR target gene down-regulated in the progression of nonalcoholic steatohepatitis

1 reference

12 December 2020

Circulating vaspin and its relationship with insulin sensitivity, adiponectin, and liver histology in subjects with non-alcoholic steatohepatitis

1 reference

12 December 2020

Serum lipocalin-2, cathepsin S and chemerin levels and nonalcoholic fatty liver disease

1 reference

12 December 2020

10.1186/S13052-014-0084-4

Identifiers

DOI

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference

2 August 2017

1 reference